Sporadic TNBC tumors and BRCA associated cancers are high grade and have p53 tumor suppressor gene mutations, overexpression of the epidermal growth factor receptor, and resistance to chemotherapy, ineffective hormonal therapy, and HER2-directed therapy, due to the triple-negative nature of the disease. The gene discussed is TP53; the disease is cancer.